Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Homoharringtonine

Homoharringtonine
Contact us for more batch information
Select Batch
Purity:99.54%
Resource Download

Homoharringtonine

Catalog No. T3380Cas No. 26833-87-4
Homoharringtonine (HHT) is a natural alkaloid that inhibits the translation of proteins and is cytotoxic. Homoharringtonine acts on the ribosomes of tumor cells to inhibit the elongation step of protein translation, thereby inhibiting protein synthesis, and has antitumor activity.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
5 mg$50In Stock
10 mg$77In Stock
25 mg$123In Stock
50 mg$219In Stock
100 mg$313In Stock
1 mL x 10 mM (in DMSO)$68In Stock
Bulk & Custom
Add to Cart

Related Compound Libraries of "Homoharringtonine"

Product Introduction

Bioactivity
Description
Homoharringtonine (HHT) is a natural alkaloid that inhibits the translation of proteins and is cytotoxic. Homoharringtonine acts on the ribosomes of tumor cells to inhibit the elongation step of protein translation, thereby inhibiting protein synthesis, and has antitumor activity.
In vitro
METHODS: Human lung cancer cells A549 and NCI-H1975 were treated with Homoharringtonine (1-6 µM) for 24-48 h. Cell viability was measured by MTT assay.
RESULTS: Homoharringtonine was moderately cytotoxic to A549 with an IC50 of 3.7 µM. H1975 cells were more sensitive to Homoharringtonine with an IC50 of 0.7 µM. [1]
METHODS: Melanoma cells A375 and B16F10 were treated with Homoharringtonine (100 nM) for 48 h. Cell cycle and apoptosis were detected by Flow cytometry.
RESULTS: Homoharringtonine induced apoptosis and G2/M cell cycle arrest in A375 and B16F10 cells. [2]
In vivo
METHODS: To detect anti-tumor activity in vivo, Homoharringtonine (10 mg/kg) was intraperitoneally injected five times a week for three weeks into nude immunodeficient mice harboring human lung cancer tumor H1975.
RESULTS: Homoharringtonine effectively inhibited tumor growth, and STAT3 phosphorylation and MCL1 levels were significantly reduced in the Homoharringtonine-treated group. [1]
METHODS: To investigate the antitumor activity in vivo, Homoharringtonine (0.7 mg/kg) was administered by gavage to NOD/SCID mice bearing ccRCC tumor grafts twice daily for 28 days.
RESULTS: Two tumor graft lines, XP26 and XP144, showed observable tumor growth inhibition following Homoharringtonine treatment. For XP26 tumors, tumor growth was inhibited by 63.7% in Homoharringtonine-treated mice compared to vector-treated mice, while tumor growth was inhibited by 43.0% in XP144 mice. [3]
Cell Research
Homoharringtonine (HHT) is dissolved in PBS at a stock solution of 2.5?mM and kept at ?20°C[1]. Human NSCLC cell lines MCF-10A, A549 and H1975 cells are seeded into 96-well plate and precultured for 24?h, then treated with Homoharringtonine for 24?h or 48?h. Cell cytotoxicity is determined by MTT assay. The absorbance is measured at 570?nm by Varioskan Flash Multimode Reader, and the cell death rate is calculated. Cell viability is estimated by trypan blue dye exclusion assay. The cells which exclude the dye are viable. Place 0.5?mL of a suitable cell suspension (dilute cells in complete medium without serum to 1×106 cells per mL) following adding 0.1?mL of 0.4% trypan blue dye and mixing thoroughly, and then incubate at room temperature for 3?min and load into a hemacytometer to count cells in three separate fields (nonviable, deep blue cells as well as viable, clear cells). The cell viability rate is calculated. After staining with Hoechst 33258 at 10?mg/mL for 10?min, cell death is observed by a fluorescence microscope[1].
AliasMyelostat, Ceflatonin, HHT, Omacetaxine mepesuccinate
Chemical Properties
Molecular Weight545.62
FormulaC29H39NO9
Cas No.26833-87-4
Storage & Solubility Information
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility Information
5% DMSO+95% Saline: 4.55 mg/mL (8.34 mM)
Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.: Soluble
DMSO: 50 mg/mL (91.64 mM)
Solution Preparation Table
DMSO/5% DMSO+95% Saline
1mg5mg10mg50mg
1 mM1.8328 mL9.1639 mL18.3278 mL91.6389 mL
5 mM0.3666 mL1.8328 mL3.6656 mL18.3278 mL
DMSO
1mg5mg10mg50mg
10 mM0.1833 mL0.9164 mL1.8328 mL9.1639 mL
20 mM0.0916 mL0.4582 mL0.9164 mL4.5819 mL
50 mM0.0367 mL0.1833 mL0.3666 mL1.8328 mL
100 mM0.0183 mL0.0916 mL0.1833 mL0.9164 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords